Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Matthijs

Showing results (151-160 of 294) with videos related to

Pageof 30
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2002
Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarctionS Matthijs Boekholdt, Mieke D Trip, Ron J G Peters, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2012
Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population studyDeepti Gurdasani, Barbara Sjouke, Sotirios Tsimikas, et al.
American Heart Journal|December 24, 2003
Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular eventsS Matthijs Boekholdt, Ron J G Peters, Moniek P M de Maat, et al.
Open Heart|February 4, 2025
Revealing the limitations of 10-year MACE observations: 20-year observed total cardiovascular burden in the EPIC-Norfolk studyTinka J van Trier, Marjolein Snaterse, Jannick An Dorresteijn, et al.
International Journal of Cardiology|July 21, 2019
Validation of the Systematic COronary Risk Evaluation - Older Persons (SCORE-OP) in the EPIC-Norfolk prospective population studyLotte Verweij, Ron J G Peters, Wilma J M Scholte Op Reimer, et al.
International Journal of Cardiology|September 30, 2018
Aortic dissection and prophylactic surgery in congenital heart diseaseJoey M Kuijpers, Dave R Koolbergen, Maarten Groenink, et al.
Circulation. Cardiovascular Quality and Outcomes|May 14, 2016
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes StudyLotte Kaasenbrood, Neil R Poulter, Peter S Sever, et al.
Circulation|September 1, 2004
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population studyS Matthijs Boekholdt, Jan-Albert Kuivenhoven, Nicholas J Wareham, et al.
Heart (British Cardiac Society)|October 1, 2021
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosisYannick Kaiser, Nick S Nurmohamed, Jeffrey Kroon, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 11, 2021
Retrospective Camera-Based Respiratory Gating in Clinical Whole-Heart 4D Flow MRILukas M Gottwald, Carmen P S Blanken, João Tourais, et al.
Pageof 30

Showing results (151-160 of 294) with videos related to

Sort By:
Pageof 30
Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2002
Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarctionS Matthijs Boekholdt, Mieke D Trip, Ron J G Peters, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2012
Lipoprotein(a) and risk of coronary, cerebrovascular, and peripheral artery disease: the EPIC-Norfolk prospective population studyDeepti Gurdasani, Barbara Sjouke, Sotirios Tsimikas, et al.
American Heart Journal|December 24, 2003
Interaction between a genetic variant of the platelet fibrinogen receptor and fibrinogen levels in determining the risk of cardiovascular eventsS Matthijs Boekholdt, Ron J G Peters, Moniek P M de Maat, et al.
Open Heart|February 4, 2025
Revealing the limitations of 10-year MACE observations: 20-year observed total cardiovascular burden in the EPIC-Norfolk studyTinka J van Trier, Marjolein Snaterse, Jannick An Dorresteijn, et al.
International Journal of Cardiology|July 21, 2019
Validation of the Systematic COronary Risk Evaluation - Older Persons (SCORE-OP) in the EPIC-Norfolk prospective population studyLotte Verweij, Ron J G Peters, Wilma J M Scholte Op Reimer, et al.
International Journal of Cardiology|September 30, 2018
Aortic dissection and prophylactic surgery in congenital heart diseaseJoey M Kuijpers, Dave R Koolbergen, Maarten Groenink, et al.
Circulation. Cardiovascular Quality and Outcomes|May 14, 2016
Development and Validation of a Model to Predict Absolute Vascular Risk Reduction by Moderate-Intensity Statin Therapy in Individual Patients With Type 2 Diabetes Mellitus: The Anglo Scandinavian Cardiac Outcomes Trial, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, and Collaborative Atorvastatin Diabetes StudyLotte Kaasenbrood, Neil R Poulter, Peter S Sever, et al.
Circulation|September 1, 2004
Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population studyS Matthijs Boekholdt, Jan-Albert Kuivenhoven, Nicholas J Wareham, et al.
Heart (British Cardiac Society)|October 1, 2021
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosisYannick Kaiser, Nick S Nurmohamed, Jeffrey Kroon, et al.
Journal of Magnetic Resonance Imaging : JMRI|March 11, 2021
Retrospective Camera-Based Respiratory Gating in Clinical Whole-Heart 4D Flow MRILukas M Gottwald, Carmen P S Blanken, João Tourais, et al.
Pageof 30